Koninklijke Philips NV (PHG)
32.74
+1.17
(+3.71%)
USD |
NYSE |
Sep 27, 16:00
32.73
-0.01
(-0.03%)
After-Hours: 20:00
Koninklijke Philips Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | -157.20M |
| September 30, 2016 | -493.28M |
| June 30, 2016 | -244.81M |
| March 31, 2016 | -313.30M |
| December 31, 2015 | -138.11M |
| September 30, 2015 | -251.71M |
| June 30, 2015 | -232.39M |
| March 31, 2015 | -1.433B |
| December 31, 2014 | -350.41M |
| September 30, 2014 | -271.01M |
| June 30, 2014 | -446.02M |
| March 31, 2014 | -241.12M |
| December 31, 2013 | -251.42M |
| September 30, 2013 | -316.08M |
| June 30, 2013 | -202.39M |
| March 31, 2013 | -374.92M |
| December 31, 2012 | -154.01M |
| September 30, 2012 | -331.21M |
| June 30, 2012 | -329.20M |
| March 31, 2012 | -100.96M |
| December 31, 2011 | -591.94M |
| September 30, 2011 | -368.89M |
| June 30, 2011 | -536.51M |
| March 31, 2011 | -280.41M |
| December 31, 2010 | -248.87M |
| Date | Value |
|---|---|
| September 30, 2010 | -85.48M |
| June 30, 2010 | -306.16M |
| March 31, 2010 | -150.82M |
| December 31, 2009 | -189.53M |
| September 30, 2009 | -448.56M |
| June 30, 2009 | -227.79M |
| March 31, 2009 | 560.49M |
| December 31, 2008 | -392.35M |
| September 30, 2008 | 1.184B |
| June 30, 2008 | 1.232B |
| March 31, 2008 | -6.782B |
| December 31, 2007 | 3.421B |
| September 30, 2007 | -651.46M |
| June 30, 2007 | 2.053B |
| March 31, 2007 | 625.87M |
| December 31, 2006 | -997.47M |
| September 30, 2006 | 7.352B |
| June 30, 2006 | -548.31M |
| March 31, 2006 | -1.046B |
| December 31, 2005 | -467.27M |
| September 30, 2005 | 1.555B |
| June 30, 2005 | 890.74M |
| March 31, 2005 | -380.37M |
| December 31, 2004 | 1.347B |
| September 30, 2004 | 189.63M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -0.743M |
| argenx SE | -513.76M |
| NuCana PLC | -0.0053M |
| NewAmsterdam Pharma Co NV | -0.209M |
| uniQure NV | 77.94M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | 1.45% |